ADAPTIVE BIOTECHNOLOGIES CORPORATION00650F109US00650F109306/05/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement. SECTION 14A SAY-ON-PAY VOTES2448460FOR244846FOR0ADMA BIOLOGICS, INC.000899104US000899104606/02/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES4672330FOR467233FOR0AKERO THERAPEUTICS, INC00973Y108US00973Y108212/02/2025To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES7635230FOR763523FOR0AMYLYX PHARMACEUTICALS, INC.03237H101US03237H101406/04/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES56959940FOR5695994FOR0APOGEE THERAPEUTICS, INC.03770N101US03770N101906/09/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES3325490FOR332549FOR0ARTIVION, INC.228903100US228903100505/12/2026To approve, by non-binding vote, the compensation paid to Artivion's Named Executive Officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion. SECTION 14A SAY-ON-PAY VOTES14150770FOR1415077FOR0ASTRIA THERAPEUTICS, INC.04635X102US04635X102801/21/2026To cast a vote, on a non-binding, advisory basis, to approve the Merger-related named executive officer compensation as disclosed in the table entitled "Golden Parachute Compensation" and its accompanying footnotes which is included in the section of the proxy statement entitled "The Merger-Interests of Astria's Directors and Executive Officers in the Merger," as required by Section 14A of the Securities Exchange Act of 1934, as amended, which was enacted as part of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. SECTION 14A SAY-ON-PAY VOTES44608270FOR4460827FOR0AVADEL PHARMACEUTICALS PLCG29687103IE00BDGMC59401/12/2026Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction. SECTION 14A SAY-ON-PAY VOTES999580FOR99958FOR0AXOGEN, INC.05463X106US05463X106306/23/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement. SECTION 14A SAY-ON-PAY VOTES4254560FOR425456FOR0AXSOME THERAPEUTICS, INC.05464T104US05464T104306/05/2026To approve, by non-binding advisory vote, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES99710FOR9971FOR0BIOCRYST PHARMACEUTICALS, INC.09058V103US09058V103506/11/2026To hold a non-binding, advisory vote regarding executive compensation. SECTION 14A SAY-ON-PAY VOTES39502680FOR3950268FOR0BIODESIX, INC.09075X207US09075X207105/19/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES1086940FOR108694FOR0BIODESIX, INC.09075X207US09075X207105/19/2026To approve, on a non-binding advisory basis, the frequency of solicitation of advisory votes to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTES1086940FOR108694FOR0BOSTON SCIENTIFIC CORPORATION101137107US101137107704/30/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES774550FOR77455FOR0CELCUITY INC.15102K100US15102K100705/14/2026To approve, on an advisory basis, named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES18475650FOR1847565FOR0COGENT BIOSCIENCES, INC.19240Q201US19240Q201206/09/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES156770FOR15677FOR0CORCEPT THERAPEUTICS INCORPORATED218352102US218352102805/21/2026To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. SECTION 14A SAY-ON-PAY VOTES1637260FOR163726FOR0CORVUS PHARMACEUTICALS, INC.221015100US221015100506/11/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES12559210FOR1255921FOR0CRESCENT BIOPHARMA, INC.G2545C104KYG2545C104206/02/2026To approve, on a non-binding, advisory basis, the compensation of Crescent Biopharma, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES2069420FOR206942FOR0CRESCENT BIOPHARMA, INC.G2545C104KYG2545C104206/02/2026To vote, on a non-binding advisory basis, on the frequency of future advisory votes to approve compensation for Crescent Biopharma, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES2069420FOR206942FOR0CUMBERLAND PHARMACEUTICALS INC.230770109US230770109204/21/2026To provide advisory approval of the compensation of the Company's named executive officers, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES3335720FOR333572FOR0CUMBERLAND PHARMACEUTICALS INC.230770109US230770109204/21/2026To provide advisory approval of the frequency of the advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES3335720FOR333572FOR0CYTOMX THERAPEUTICS, INC.23284F105US23284F105706/17/2026To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. SECTION 14A SAY-ON-PAY VOTES66690550FOR6669055FOR0CYTOMX THERAPEUTICS, INC.23284F105US23284F105706/17/2026To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES66690550FOR6669055FOR0DAMORA THERAPEUTICS, INC.36322Q206US36322Q206606/17/2026To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES11040660FOR1104066FOR0DAMORA THERAPEUTICS, INC.36322Q206US36322Q206606/17/2026To conduct an advisory vote to determine the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES11040660FOR1104066FOR0DYNE THERAPEUTICS, INC.26818M108US26818M108006/05/2026To vote, on an advisory basis, to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES10235970FOR1023597FOR0EDESA BIOTECH INC27966L306CA27966L306505/27/2026Advisory Vote on Executive Compensation: Approve, on an advisory basis, our executive compensation ("Say on Pay"). SECTION 14A SAY-ON-PAY VOTES5615220FOR561522FOR0EDGEWISE THERAPEUTICS INC28036F105US28036F105706/04/2026Conduct an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES24329690FOR2432969FOR0EVOLUS, INC.30052C107US30052C107106/11/2026Approval of, on an advisory basis, the compensation of Evolus' named executive officers. SECTION 14A SAY-ON-PAY VOTES12792530FOR1279253FOR0EXACT SCIENCES CORPORATION30063P105US30063P105702/20/2026Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Exact Sciences Corporation's named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement (the "Compensation Proposal"). SECTION 14A SAY-ON-PAY VOTES5834280FOR583428FOR0EXAGEN INC30068X103US30068X103706/09/2026To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES1148930FOR114893FOR0GUARDANT HEALTH, INC.40131M109US40131M109906/17/2026Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES60070FOR6007FOR0GUARDANT HEALTH, INC.40131M109US40131M109906/17/2026Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES60070FOR6007FOR0IMMUNOVANT, INC.45258J102US45258J102508/27/2025To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES1292580FOR129258FOR0INTUITIVE SURGICAL, INC.46120E602US46120E602304/30/2026To approve, by advisory vote, the compensation of the Company's Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES164900FOR16490FOR0IONIS PHARMACEUTICALS, INC.462222100US462222100406/04/2026To make an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES213670FOR21367FOR0IOVANCE BIOTHERAPEUTICS, INC.462260100US462260100706/10/2026To approve, by non-binding advisory vote, the compensation of our namedexecutive offi cers.SECTION 14A SAY-ON-PAY VOTES25000FOR2500FOR0IRHYTHM HOLDINGS, INC.450056106US450056106705/27/2026To approve, on a non-binding advisory basis, the named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES135600FOR13560FOR0LEONABIO, INC.04746L203US04746L203406/22/2026To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES18580600FOR1858060FOR0LEONABIO, INC.04746L203US04746L203406/22/2026To approve, on an advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES18580600FOR1858060FOR0MEDLINE INC.58507V107US58507V107006/11/2026Advisory Vote to Approve Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES280000FOR28000FOR0MEDLINE INC.58507V107US58507V107006/11/2026Advisory Vote on the Frequency of Votes on Our Executive Compensation. SECTION 14A SAY-ON-PAY VOTES280000FOR28000FOR0MERUS N.V.N5749R100NL001160626412/09/2025Non-binding advisory proposal to approve certain compensation arrangements SECTION 14A SAY-ON-PAY VOTES12882180FOR1288218FOR0NATERA, INC.632307104US632307104206/11/2026To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES17160FOR1716FOR0NATERA, INC.632307104US632307104206/11/2026To approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES17160FOR1716FOR0NAUTILUS BIOTECHNOLOGY, INC.63909J108US63909J108806/17/2026Approval on an advisory basis of the compensation of our named executive officers for the fiscal year ended December 31, 2025 (the "Say on Pay Vote"). SECTION 14A SAY-ON-PAY VOTES118893270FOR11889327FOR0NAUTILUS BIOTECHNOLOGY, INC.63909J108US63909J108806/17/2026Approval on an advisory basis of the frequency of future Say on Pay Votes. SECTION 14A SAY-ON-PAY VOTES118893270FOR11889327FOR0NEUMORA THERAPEUTICS, INC.640979100US640979100005/27/2026Advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES42884710FOR4288471FOR0NEUMORA THERAPEUTICS, INC.640979100US640979100005/27/2026Advisory vote on the frequency of future advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES42884710FOR4288471FOR0NEUROCRINE BIOSCIENCES, INC.64125C109US64125C109905/27/2026Advisory vote on the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES650500FOR65050FOR0NURIX THERAPEUTICS, INC.67080M103US67080M103605/15/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES23072700FOR2307270FOR0NUVALENT, INC.670703107US670703107506/16/2026To approve, on an advisory basis, the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES5377430FOR537743FOR0OPUS GENETICS, INC.67577R102US67577R102304/20/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES26429690FOR2642969FOR0ORCHESTRA BIOMED HOLDINGS, INC.68572M106US68572M106206/23/2026Adoption of an advisory (non-binding) resolution approving the compensation of our "named executive officers". SECTION 14A SAY-ON-PAY VOTES28694890FOR2869489FOR0ORCHESTRA BIOMED HOLDINGS, INC.68572M106US68572M106206/23/2026Advisory (non-binding) vote on the frequency of future advisory (non-binding) votes on the compensation of our "named executive officers". SECTION 14A SAY-ON-PAY VOTES28694890FOR2869489FOR0ORUKA THERAPEUTICS, INC.687604108US687604108706/02/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES10768290FOR1076829FOR0OSCAR HEALTH, INC.687793109US687793109606/04/2026Advisory vote to approve named executive officer compensation ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES70620FOR7062FOR0PALISADE BIO, INC.696389402US696389402606/10/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES95050650FOR9505065FOR0PHATHOM PHARMACEUTICALS, INC.71722W107US71722W107105/19/2026To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES6945220FOR694522FOR0PRAXIS PRECISION MEDICINES, INC.74006W207US74006W207006/10/2026To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2026 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the compensation tables and narrative discussion. SECTION 14A SAY-ON-PAY VOTES17525270FOR1752527FOR0PROTAGONIST THERAPEUTICS, INC.74366E102US74366E102906/17/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES647010FOR64701FOR0RELAY THERAPEUTICS, INC.75943R102US75943R102306/09/2026To consider and act upon an advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES77565040FOR7756504FOR0REPLIGEN CORPORATION759916109US759916109505/14/2026Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES3300FOR330FOR0REVOLUTION MEDICINES, INC.76155X100US76155X100006/18/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES2910540FOR291054FOR0RHYTHM PHARMACEUTICALS, INC.76243J105US76243J105106/24/2026Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. SECTION 14A SAY-ON-PAY VOTES15051790FOR1505179FOR0ROIVANT SCIENCES LTD.G76279101BMG76279101709/10/2025To cast a non-binding, advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES31629480FOR3162948FOR0SOLID BIOSCIENCES INC.83422E204US83422E204606/10/2026The approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES110559000FOR11055900FOR0SPYRE THERAPEUTICS INC.00773J202US00773J202405/27/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES25874910FOR2587491FOR0SURROZEN, INC.86889P208US86889P208305/13/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES2029000FOR202900FOR0SURROZEN, INC.86889P208US86889P208305/13/2026Advisory vote on the preferred frequency of the advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES2029000FOR202900FOR0SUTRO BIOPHARMA, INC.869367201US869367201106/05/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES7147530FOR714753FOR0TANGO THERAPEUTICS, INC.87583X109US87583X109006/04/2026To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES11185770FOR1118577FOR0TRAVERE THERAPEUTICS, INC.89422G107US89422G107605/19/2026To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES23811600FOR2381160FOR0TRAVERE THERAPEUTICS, INC.89422G107US89422G107605/19/2026To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES23811600FOR2381160FOR0VERONA PHARMA PLC925050106US925050106409/24/2025To approve, on an advisory, non-binding basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Transaction, as disclosed in the table entitled "Potential Payments to Named Executive Officers" beginning on page 70 of the proxy statement, including the associated narrative discussion, and the agreements or understandings pursuant to which such compensation may be paid or become payable. SECTION 14A SAY-ON-PAY VOTES28735540FOR2873554FOR0VERONA PHARMA PLC925050106US925050106409/24/2025To approve, on an advisory, non-binding basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Transaction, as disclosed in the table entitled "Potential Payments to Named Executive Officers" beginning on page 70 of the proxy statement, including the associated narrative discussion, and the agreements or understandings pursuant to which such compensation may be paid or become payable. SECTION 14A SAY-ON-PAY VOTES4930000FOR493000FOR0VIRIDIAN THERAPEUTICS, INC.92790C104US92790C104506/02/2026To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES6866690FOR686669FOR0VIRIDIAN THERAPEUTICS, INC.92790C104US92790C104506/02/2026To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES6866690FOR686669FOR0X4 PHARMACEUTICALS, INC.98420X202US98420X202705/11/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES63144520FOR6314452FOR0ZYMEWORKS INC.98985Y108US98985Y108212/30/2025Advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES6545450FOR654545FOR0VYOME HOLDINGS, INC92943X104US92943X104610/28/2025Approve the advisory, non-binding vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES00ABSTAIN0FOR0